MedPath

RISING PHARMA HOLDINGS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

126

FDA:126

Drug Approvals

Chlorzoxazone

Approval Date
Sep 17, 2025
FDA

Mirtazapine

Approval Date
Sep 12, 2025
FDA

Mirtazapine

Approval Date
Sep 11, 2025
FDA

PREGABALIN

Approval Date
Sep 5, 2025
FDA

Dexamethasone

Approval Date
Sep 5, 2025
FDA

Ondansetron Hydrochloride

Approval Date
Sep 1, 2025
FDA

Levetiracetam

Approval Date
Aug 20, 2025
FDA

SODIUM CITRATE AND CITRIC ACID

Approval Date
May 15, 2025
FDA

Memantine Hydrochloride

Approval Date
Apr 19, 2025
FDA

Albuterol Sulfate

Approval Date
Apr 17, 2025
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.